Development of eugenol derivatives with 5-LOX inhibitory activity

dc.contributor.authorFilho, José L. Pereirapor
dc.contributor.authorPereira, Renato B.por
dc.contributor.authorVieira, Tatiana F.por
dc.contributor.authorSousa, Sérgio F.por
dc.contributor.authorCoelho, José Ricardo Alvespor
dc.contributor.authorPinto, Nuno F. S.por
dc.contributor.authorCoelho, Catarina M. M.por
dc.contributor.authorFernandes, Maria José Gomespor
dc.contributor.authorCastanheira, Elisabete M. S.por
dc.contributor.authorGonçalves, M. Sameiro T.por
dc.contributor.authorPereira, David M.por
dc.date.accessioned2025-09-05T10:43:52Z
dc.date.available2025-09-05T10:43:52Z
dc.date.issued2025-08-21
dc.description.abstractEugenol (4-allyl-2-methoxyphenol), is the major chemical constituent in the essential oil of numerous plant species. Several biological properties have been described for this molecule, including modulation of enzymatic targets relevant for the inflammatory response, such as 5-lipoxygenase (5-LOX). As so, there is interest in expanding the chemical space of this molecule to develop new molecules to be used in inflammatory conditions. We describe the chemometric analysis of several eugenol derivatives, which show that the chemical space of the parent molecule was successfully expanded. All molecules were evaluated for their inhibition towards 5-LOX, an important player in inflammatory pathways. Four derivatives exhibited significant 5-LOX inhibitory activity, which prompted further studies. The most promising compounds, 4-allylbenzene-1,2-diol 2, ethyl-4-(4-allyl-2-methoxyphenoxy)butanoate 4e, 3-(2-methoxy-4-(oxiran-2-ylmethyl)phenoxy)propyl acetate 5d and 4-(3-(tert-butoxy)-2-hydroxypropyl)-2-methoxyphenol 7c, were submitted to in silico assays to validate their affinity and stability towards 5-LOX, which helped clarify the mechanism by which these molecules interact and inhibit this enzyme.por
dc.description.sponsorshipThe work was supported through projects UIDB/50006/2020, UIDP/50006/2020 and PTDC/ASP-AGR/30154/2017 (PO-CI-01–0145-FEDER-030154) of COMPETE 2020, funded by FCT (Fundação para a Ciência e Tecnologia, Portugal)/MCTES (Ministério da Ciência, Tecnologia e Ensino Superior) through national funds. Renato B. Pereira thanks FCT - Fundação para Ciência e a Tecnologia, I.P. for the funding through project PTDC-QUI/2870/2020. The authors acknowledge also to FCT, and FEDER-COMPETE-QREN-EU for financial support to the research centre CQUM (UID/QUI/00686/2020). The NMR spectrometer Bruker Avance III 400 is part of the National NMR Network (PTNMR) and is partially supported by Infrastructure Project No 022161 (co-financed by FEDER through COMPETE 2020, POCI and PORL and FCT through PIDDAC).por
dc.distributioninternationalpor
dc.identifier.articlenumber2535586por
dc.identifier.citationJosé L. Pereira Filho, Renato B. Pereira, Tatiana F. Vieira, Sérgio F. Sousa, José R. A. Coelho, Nuno F. S. Pinto, Catarina M. M. Coelho, Maria José G. Fernandes, Elisabete M. S. Castanheira, Maria S. T. Gonçalves & David M. Pereira (2025) Development of eugenol derivatives with 5-LOX inhibitory activity, Journal of Enzyme Inhibition and Medicinal Chemistry, 40:1, 2535586, DOI: 10.1080/14756366.2025.2535586por
dc.identifier.doi10.1080/14756366.2025.2535586por
dc.identifier.issn1475-6366por
dc.identifier.pmid40842071por
dc.identifier.urihttps://hdl.handle.net/1822/97043
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherTaylor & Francispor
dc.relationinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FQUI-QFI%2F2870%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FASP-AGR%2F30154%2F2017/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50006%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00686%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04650%2F2020/PTpor
dc.relation.publisherversionhttps://www.tandfonline.com/doi/full/10.1080/14756366.2025.2535586por
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/por
dc.subjectChemometricspor
dc.subjectEugenolpor
dc.subject5-Lipoxygenasepor
dc.subjectIn silicopor
dc.subject.fosCiências Médicas::Ciências da Saúdepor
dc.subject.fosCiências Naturais::Ciências Químicaspor
dc.subject.odsSaúde de qualidadepor
dc.subject.odsCidades e comunidades sustentáveispor
dc.subject.odsProdução e consumo sustentáveispor
dc.subject.odsProteger a vida terrestrepor
dc.titleDevelopment of eugenol derivatives with 5-LOX inhibitory activitypor
dc.typearticlepor
dspace.entity.typePublicationen
oaire.citationIssue1por
oaire.citationVolume40por
oaire.versionVoRpor
sdum.journalJournal of Enzyme Inhibition and Medicinal Chemistrypor

Ficheiros

Pacote original

A mostrar 1 - 2 de 2
A carregar...
Nome:
Development of eugenol derivatives with 5-LOX inhibitory activity.pdf
Tamanho:
7.66 MB
Formato:
Adobe Portable Document Format
Descrição:
Article
A carregar...
Nome:
Supplementary Info.pdf
Tamanho:
765.93 KB
Formato:
Adobe Portable Document Format
Descrição:
Supplementary Info